Everett Harris & CO Embecta Corp. Transaction History

Everett Harris & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$12.87 - $19.09 $8,622 - $12,790	-670 Reduced 6.22%	10,107 $191,000
Q3 2023 Oct 23, 2023	SELL	$15.0 - $22.17 $1,065 - $1,574	-71 Reduced 0.65%	10,777 $162,000
Q2 2023 Jul 26, 2023	SELL	$21.6 - $30.69 $10,800 - $15,345	-500 Reduced 4.41%	10,848 $234,000
Q1 2023 Apr 24, 2023	SELL	$23.07 - $32.77 $16,818 - $23,889	-729 Reduced 6.04%	11,348 $319,000
Q4 2022 Jan 20, 2023	SELL	$25.29 - $35.48 $9,382 - $13,163	-371 Reduced 2.98%	12,077 $0
Q3 2022 Oct 21, 2022	SELL	$24.0 - $33.42 $179,952 - $250,583	-7,498 Reduced 37.59%	12,448 $358,000
Q2 2022 Jul 22, 2022	BUY	$24.78 - $33.36 $494,261 - $665,398	19,946 New	19,946 $505,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

Stay updated on Everett Harris & CO with notifications on news.